Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Nicholas A. P. S. Buss"'
Autor:
Richard T. George, Liron Abuhatzira, Susan M. Stoughton, Sotirios K. Karathanasis, Dewei She, ChaoYu Jin, Nicholas A. P. S. Buss, Rebecca Bakker‐Arkema, Emily L. Ongstad, Michael Koren, Boaz Hirshberg
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 13 (2021)
Background MEDI6012 is recombinant human lecithin cholesterol acyltransferase, the rate‐limiting enzyme in reverse cholesterol transport. Infusions of lecithin cholesterol acyltransferase have the potential to enhance reverse cholesterol transport
Externí odkaz:
https://doaj.org/article/1a70f3f882f34faebeab6817f3357b2e
Autor:
Michael J. Koren, ChaoYu Jin, Rebecca Bakker-Arkema, Liron Abuhatzira, Dewei She, Boaz Hirshberg, Richard T George, Emily L. Ongstad, Nicholas A P S Buss, Susan M Stoughton, Sotirios K. Karathanasis
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background MEDI6012 is recombinant human lecithin cholesterol acyltransferase, the rate‐limiting enzyme in reverse cholesterol transport. Infusions of lecithin cholesterol acyltransferase have the potential to enhance reverse cholesterol transport
Autor:
Jiefen Munley, Andrew Whittaker, Nicholas A P S Buss, Ahmad Ebrahimi, David Brott, Amy Pointon, Paul D. Hockings, Joel S. Raichlen, Ali Khalil, Li-Ming Gan, James Cartwright, Christer Gottfridsson, Pavlo Garkaviy, Johannes Wikström, Richard T George
Publikováno v:
Expert opinion on drug safety. 19(3)
Introduction: Drug-induced myocardial dysfunction is an important safety concern during drug development. Oncology compounds can cause myocardial dysfunction, leading to decreased left ventricular ejection fraction and heart failure via several mecha
Autor:
Patricia O. Cover, Nicholas A. P. S. Buss, Julia C. Buckingham, Felicity N. E. Gavins, Andrea Terron
Publikováno v:
The FASEB Journal. 29:2930-2942
Hypothalamo-pituitary-adrenocortical dysfunction contributes to morbidity and mortality in a high proportion of patients with sepsis. Here, we provide new insights into the underlying adrenal pathology. Using a murine model of endotoxemia (LPS inject
Autor:
Ellen L Hughes, Julia C. Buckingham, Felicity N. E. Gavins, Paul M. Holloway, Stephen J. Getting, Nicholas A. P. S. Buss
Publikováno v:
The FASEB Journal. 26:4977-4989
Unregulated inflammation underlies many diseases, including sepsis. Much interest lies in targeting anti-inflammatory mechanisms to develop new treatments. One such target is the anti-inflammatory protein annexin A1 (AnxA1) and its receptor, FPR2/ALX
Autor:
C. D. John, Julia C. Buckingham, Patricia O. Cover, Felicity N. E. Gavins, Nicholas A. P. S. Buss
Publikováno v:
Current Opinion in Pharmacology. 8:765-776
Annexin A1 (ANXA1, formerly termed lipocortin 1 or macrocortin) is an important protein mediator of the feedback actions of glucocorticoids within the hypothalamo-pituitary-adrenocortical (HPA) axis. Here we consider the mechanisms by which ANXA1 exe
Publikováno v:
The FASEB Journal. 25